Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IceCure Medical (ICCM) Shares Outstanding (Weighted Average) (2020 - 2026)

IceCure Medical has reported Shares Outstanding (Weighted Average) over the past 7 years, most recently at $60.0 for Q1 2026.

  • For Q1 2026, Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $60.0; the TTM value through Mar 2026 reached $60.0, changed 0.0%, while the annual FY2025 figure was $63.6 million, 24.97% up from the prior year.
  • Shares Outstanding (Weighted Average) was $60.0 for Q1 2026 at IceCure Medical, down from $63.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $63.6 million in Q4 2025 and bottomed at $60.0 in Q1 2025.
  • The 5-year median for Shares Outstanding (Weighted Average) is $41.3 million (2022), against an average of $32.9 million.
  • Year-over-year, Shares Outstanding (Weighted Average) rose 29.66% in 2022 and then changed 0.0% in 2026.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $37.0 million in 2022, then grew by 23.29% to $45.6 million in 2023, then increased by 11.48% to $50.9 million in 2024, then rose by 24.97% to $63.6 million in 2025, then crashed by 100.0% to $60.0 in 2026.
  • The last three reported values for Shares Outstanding (Weighted Average) were $60.0 (Q1 2026), $63.6 million (Q4 2025), and $60.0 (Q1 2025) per Business Quant data.